A股異動 | 中國船舶升5% 手持訂單183艘 交船期安排至2027年
格隆匯3月21日丨中國船舶(600150.SH)升5.35%,報25.72元,總市值1150億元。據中國船舶集團3月17日消息,2023年第一季度,中國船舶集團有限公司旗下上海三大船企——滬東中華造船(集團)有限公司、江南造船(集團)有限責任公司和上海外高橋造船有限公司接連不斷傳出生產喜訊。據瞭解,上海三大船企去年完工交船48艘,新接訂單72艘,累計手持訂單已達183艘,交船期已安排至2027年。目前,三大船企各在建生產項目正快速有序推進。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.